↓ Read PDF
01 · ABSTRACT

Abstract

Background: Racial/ethnic and socioeconomic disparities in diabetes and hypertension outcomes persist in the United States (U.S.), and worsened during the COVID-19 pandemic. This was in part due to suboptimal implementation of telehealth in U.S. safety-net settings alongside the pre-existing “digital divide” – structural determinants that limit access to digital tools by marginalized communities. To improve health equity, it is critical that health systems in the U.S. integrate principles of digital and health literacy for more equitable chronic disease care.

Methods: We are conducting a 2x2 factorial randomized controlled trial, in partnership with a Community Advisory Board, assessing a multi-level intervention addressing barriers that affect the equitable use of telehealth amongst low-income patients in San Francisco County. Patient-level support is provided through the evidence-based strategies of health coaching and digital navigation (“digital coaching”); clinic-level support includes equity dashboards, patient advisory councils, and practice facilitation. We are randomizing 600 low-income, racially/ethnically diverse English and Spanish-speaking patients with uncontrolled diabetes to receive digital coaching (n=200) vs. usual care (n=400) for 3 months; and 11 public health primary care clinics to clinic support vs. usual care for 24 months. We aim to evaluate the impact of patient and clinic level interventions to determine individual effectiveness and potential synergistic impact on clinical and process measures related to diabetes and telehealth outcomes.

Results: The study's primary clinical outcome is change in patient-level Hemoglobin A1C (A1c); the primary process outcome is patient portal usage. Secondary clinical outcomes include changes in patient-level systolic blood pressure (SBP) and microalbuminuria (UACR), and changes in clinic-level A1c, SBP, and UACR. Secondary process outcomes assess patient-level changes in digital literacy, medication adherence, patient activation, and visit show rates, and clinic-level measures of telehealth adoption.

Discussion: The ACCTiVATE trial tests a multi-level intervention developed through a stakeholder-engaged research approach and user-centered design to be feasible and acceptable for impacted communities. If efficacious, ACCTiVATE may provide a scalable model to improve chronic health outcomes and telehealth equity among marginalized racial/ethnic populations experiencing structural and interpersonal access barriers.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 12 No 11 (2024): November Issue, Issue 11, VOl.12
SectionResearch Articles
Published29 November 2024
DOI10.18103/mra.v12i11.6087
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

Authors & affiliations

AO

Adenike Omomukuyo, MPH

Department of Medicine, Division of Nephrology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States.

AR

Andy Ramirez, BS

Department of Medicine, Division of Nephrology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States.

AD

Aliyah Davis, BS

Department of Medicine, Division of Nephrology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States.

AV

Alexandra Velasquez, MS CCRP

Department of Medicine, Division of Nephrology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States.

AN

Adriana L Najmabadi, MEA

Department of Family & Community Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA, United States.

MK

Marianna Kong, MD

Department of Family & Community Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA, United States.

RW

Rachel Willard-Grace, MPH

Department of Family & Community Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA, United States.

WB

William Brown III, PhD DrPH MA

Division of Prevention Science, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

AB

Andrew Broderick

San Francisco Tech Council, San Francisco, CA, United States.

CM

Charles E McCulloch, PhD MS MA

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

NF

Nora Franco, BA MSIS

Zuckerberg San Francisco General Hospital Medical Library, University of California, San Francisco, San Francisco, CA, United States.

US

Urmimala Sarkar, MD MPH

Division of General Internal Medicine, Zuckerberg San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.;  Action Research Center for Health Equity, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States.

CL

Courtney Lyles, PhD

UC Davis Center for Healthcare Policy and Research, UC Davis School of Medicine, University of California, Davis, Sacramento, CA, United States.

AT

Amber S Tran, BA

Health Informatics, Yale School of Public Health, New Haven, CT, United States.

AS

Anjana E Sharma, MD MAS

Department of Family & Community Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA, United States. ; Action Research Center for Health Equity, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States.

DT

Delphine S Tuot, MDCM MAS

Department of Medicine, Division of Nephrology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States. ; Action Research Center for Health Equity, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States.

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗